Budesonide Teva 0.125 mg/ml nebul. susp. amp.

País: Bélgica

Idioma: inglés

Fuente: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredientes activos:

Budesonide 0,25 mg

Disponible desde:

Teva Pharma Belgium SA-NV

Código ATC:

R03BA02

Designación común internacional (DCI):

Budesonide

Dosis:

0,125 mg/ml

formulario farmacéutico:

Nebuliser suspension

Composición:

Budesonide 0.125 mg/ml

Vía de administración:

Inhalation use

Área terapéutica:

Budesonide

Resumen del producto:

CTI code: 445822-07 - Pack size: 40 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445822-06 - Pack size: 30 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445822-09 - Pack size: 60 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445822-08 - Pack size: 50 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445822-03 - Pack size: 15 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445822-02 - Pack size: 10 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445822-05 - Pack size: 25 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445822-04 - Pack size: 20 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 445822-01 - Pack size: 5 x 2 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Estado de Autorización:

Commercialised: No

Fecha de autorización:

2013-12-19